Glaxo's Ceptaz (ceftazidime)
Executive Summary
New L-arginine formulation of the injectable, broad-spectrum antibiotic Fortaz approved Sept. 27. The firm will continue to market Fortaz, and plans to launch Ceptaz "as soon as possible." The product was "approvable" as of June 4 ("The Pink Sheet" Aug. 20, T&G-1). Glaxo submitted the Ceptaz NDA in the spring of 1989.